Serving the UMN community since 1900

The Minnesota Daily

Serving the UMN community since 1900

The Minnesota Daily

Serving the UMN community since 1900

The Minnesota Daily

Daily Email Edition

Get MN Daily NEWS delivered to your inbox Monday through Friday!

SUBSCRIBE NOW

Editorial Cartoon: Journalists in Gaza
Editorial Cartoon: Journalists in Gaza
Published February 23, 2024
A warm February night at Afton Alps. Afton Alps offers discounts for college students.
College students ski cheap at Afton Alps
Published February 23, 2024

University partnership tackles chronic pain, high blood pressure

 

The University of Minnesota has renewed a license agreement with a Minnesota startup company, International Cardio Corporation to continue researching how ultrasound technology can be used to treat hypertension, according to a University news release.

A team of University researchers, led by electrical and computer engineering professor Emad Ebbini, developed the ultrasound technology to treat atheroscleorosis — a condition that slowly blocks arteries and constricts them — by loosening the arteries through a thermal effect.

Current treatments for these conditions include catheter use and angioplasty; but they aren’t as precise as the ultrasound method, Ebbini said in the news release. The new method provides a non-invasive treatment and doesn’t damage any surrounding tissues.

CEO of ICC Dennis Selke said using ultrasound technology in this way will also reduce costs of treatment and “now that we know there is a path forward, we wanted to explore ways to treat other conditions that can respond to this [ultrasound] platform."

Now, the University and the ICC want to explore the method to see if it will work in other areas to manage chronic pain and hypertension, according to the University’s business blog. According to the Centers for Disease Control and Prevention, 1 in 3 adults suffer from high blood pressure. If successful, the method will have the potential to treat anyone with chronic pain or high blood pressure.

The next stage, Sellke said in the release, is to transition from the lab to commercial development where they can integrate the method into everyday use.

Leave a Comment

Accessibility Toolbar

Comments (0)

All The Minnesota Daily Picks Reader Picks Sort: Newest

Your email address will not be published. Required fields are marked *